116496-81-2

Basic information

• Product Name: N-(2-METHOXY-4-METHYL-6-NITROPHENYL)ACETAMIDE
• Synonyms: N-(2-METHOXY-4-METHYL-6-NITROPHENYL)ACETAMIDE
• CAS NO: 116496-81-2
• Molecular Formula: C₉H₁₀N₂O₄
• Molecular Weight: 210.19
• Mol File: 116496-81-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(2-METHOXY-4-METHYL-6-NITROPHENYL)ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-METHOXY-4-METHYL-6-NITROPHENYL)ACETAMIDE(116496-81-2)
• EPA Substance Registry System: N-(2-METHOXY-4-METHYL-6-NITROPHENYL)ACETAMIDE(116496-81-2)

Safety Data

• Hazardous Substances Data: 116496-81-2(Hazardous Substances Data)

Upstream product

• 93-26-5 2-methoxyacetanilide 
• 7697-37-2 nitric acid 
• 108-24-7 acetic anhydride 
• 90-04-0 2-methoxy-phenylamine 
• 16554-45-3 2-methoxy-6-nitroaniline 
• 75-36-5 acetyl chloride 
• 16315-07-4 2,3-dinitroanisole 
• 77-78-1 dimethyl sulfate 
• 69194-51-0 1-acetoxy-2-acetylamino-3-nitro-benzene 

Downstream Products

• 1025509-70-9 N-(2-amino-6-methoxyphenyl)acetamide 
• 1449745-40-7 C₁₄H₁₂N₂O₅ 
• 1449745-43-0 C₁₅H₁₄N₂O₆ 
• 16554-45-3 2-methoxy-6-nitroaniline 
• 15969-08-1 6-methoxy-2-nitrophenol 

Relevant articles and documents

Design, synthesis and anticancer activity evaluation of diazepinomicin derivatives

A series of diazepinomicin derivatives were synthesized and evaluated in vitro for their growth inhibitory activity against the human carcinoma cell lines. The results indicated the anticancer selectivity of this kind of compounds. Based on the results, preliminary structure-activity relationships were discussed.

Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.